Ana Isabel Farfán-Sedano

InstitutionHospital Universitario de Fuenlabrada
AddressMadrid.
Spain
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 1 publications in May 2020 and June 2020 and February 2021 and March 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 6 publications over 2 distinct years, with a maximum of 4 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients. J Infect. 2022 02; 84(2):248-288. PMID: 34437930.
      Citations:    Fields:    
    2. Demelo-Rodriguez P, Farfán-Sedano AI, Pedrajas JM, Llamas P, Sigüenza P, Jaras MJ, Quintana-Diaz M, Fernández-Capitán C, Bikdeli B, Jiménez D, Monreal M. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. J Thromb Haemost. 2021 08; 19(8):1981-1989. PMID: 34018658.
      Citations: 5     Fields:    Translation:Humans
    3. Morales-Ortega A, García de Tena J, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, Canales-Albendea MÁ, Bernal-Bello D. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors. Cancer. 2021 06 01; 127(11):1937-1938. PMID: 33721325.
      Citations: 1     Fields:    Translation:Humans
    4. Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Early clinical experience with imatinib in COVID-19: Searching for a dual effect. J Infect. 2021 05; 82(5):186-230. PMID: 33549625.
      Citations: 3     Fields:    Translation:Humans
    5. Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    6. Bernal-Bello D, Jaenes-Barrios B, Morales-Ortega A, Ruiz-Giardin JM, García-Bermúdez V, Frutos-Pérez B, Farfán-Sedano AI, de Ancos-Aracil C, Bermejo F, García-Gil M, Zapatero-Gaviria A, San Martín-López JV. Imatinib might constitute a treatment option for lung involvement in COVID-19. Autoimmun Rev. 2020 07; 19(7):102565. PMID: 32376403.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health